Utah Medical Products, Inc. (NASDAQ:UTMD) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Tuesday.

Separately, ValuEngine upgraded shares of Utah Medical Products from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th.

Shares of Utah Medical Products (NASDAQ UTMD) traded up 2.60% during mid-day trading on Tuesday, reaching $73.00. 6,129 shares of the company traded hands. The company has a market capitalization of $271.27 million, a P/E ratio of 22.03 and a beta of 0.75. Utah Medical Products has a 52 week low of $56.30 and a 52 week high of $75.00. The stock’s 50-day moving average is $71.33 and its 200-day moving average is $65.07.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Tuesday, April 25th. The medical instruments supplier reported $0.95 earnings per share for the quarter. Utah Medical Products had a net margin of 31.71% and a return on equity of 17.44%. The firm had revenue of $10.26 million during the quarter. On average, equities analysts predict that Utah Medical Products will post $2.81 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/25/bidaskclub-downgrades-utah-medical-products-inc-nasdaqutmd-to-buy.html.

An institutional investor recently raised its position in Utah Medical Products stock. Russell Investments Group Ltd. increased its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 19.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,619 shares of the medical instruments supplier’s stock after buying an additional 7,649 shares during the period. Russell Investments Group Ltd. owned about 1.28% of Utah Medical Products worth $3,448,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 65.27% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.